Search Results

The default setting for search results displays All Content. If you prefer to see recent content only, please adjust the date filter.

523 Results Found

CMS proposes new drug pricing model to expand GLP-1 access to those with Medicare Part D and Medicaid

The Centers for Medicare & Medicaid Services Dec. 23 introduced a new drug pricing model, BALANCE, for Medicare Part D and Medicaid beneficiaries.

Encore: Bridging Distances with AI and Telemedicine, and Destigmatizing Mental Health for Health Care Workers

As we close out 2025, we’re excited to share highlights from two impactful episodes of the Advancing Health podcast that sparked dialogue around improving health care in America.

CMS releases proposed rules on two drug pricing models

The Centers for Medicare & Medicaid Services Dec. 19 issued two proposed rules for implementing alternative drug pricing models. 

AHA comments on proposed ‘public charge’ rule

The AHA Dec. 19 submitted comments on the Department of Homeland Security’s proposed rule regarding the Public Charge Ground of Inadmissibility, urging the department to “exclude Medicaid and the Children’s Health Insurance Program (CHIP) from its public charge determinations.”

Administration reaches deals with 9 drug companies to lower drug costs

The White House announced Dec. 19 that it reached most-favored-nation deals with nine pharmaceutical companies, aligning their drug prices with the lowest paid by other developed nations.

AHA urges Elevance Health to rescind Anthem’s ‘Nonparticipating Provider Policy,’ citing harm to patient care access

The AHA Dec. 17 urged Elevance Health, which is the parent company of the Anthem brand of health plans, to rescind Anthem’s nonparticipating provider policy that is set to go into effect Jan. 1, citing the harm it will inflict on patients.

House passes narrow health care package; sets up a vote on EPTCs in January

The House Dec. 17 passed the Lower Health Care Premiums for All Americans Act (H.R. 6703), legislation to expand association health plans, increase transparency requirements for pharmacy benefit managers, and fund cost-sharing reductions for some Health Insurance Marketplace enrollees.

Study finds depression, anxiety raise risk of adverse cardiac event

Depression and anxiety can increase the risk of a major adverse cardiac event, according to an American Heart Association study published Dec. 17.

Blog: Putting 340B Program Growth in Context

An AHA blog examines new data released by the Health Resources and Services Administration on the growth of the 340B Drug Pricing Program.

Report finds increasing concentration in commercial health, MA insurance markets 

The American Medical Association Dec. 16 released its latest annual report on health insurance competition, finding that 97% of commercial markets were highly concentrated in 2024.